Effects of priming injections of MDMA and cocaine on reinstatement of MDMA- and cocaine-seeking in rats

Drug and Alcohol Dependence

Volumn 96, Issue 3, 2008, Pages 249-255

  Schenk, Susan ^a   Hely, Lincoln ^a   Gittings, David ^a   Lake, Barbara ^a   Daniela, Evangeline ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

Cocaine; Drug seeking; MDMA; Relapse; Self administration

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; COCAINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; EXPOSURE; INJECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RELAPSE; SENSITIZATION; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; COCAINE; CONDITIONING, OPERANT; CUES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTINCTION, PSYCHOLOGICAL; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; SELF ADMINISTRATION;

ANIMALIA; RATTUS;

EID: 46549088297     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2008.03.014     Document Type: Article

References (54)

1. Alex K.D., and Pehek E.A. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol. Ther. 113 (2007) 296-320
2. Anderson S.M., and Pierce R.C. Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharmacol. Ther. 106 (2005) 389-403
3. Ball K.T., Walsh K.M., and Rebec G.V. Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues. Pharmacol. Biochem. Behav. 87 (2007) 420-425
4. Beardsley P.M., Balster R.L., and Harris L.S. Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug Alcohol Depend. 18 (1986) 149-157
5. Brennan K.A., and Schenk S. Initial deficit and recovery of function after MDMA preexposure in rats. Psychopharmacology 184 (2006) 239-246
6. Cole J.C., Bailey M., Sumnall H.R., Wagstaff G.F., and King L.A. The content of ecstasy tablets: implications for the study of their long-term effects. Addiction 97 (2002) 1531-1536
7. Cottler L.B., Womack S.B., Compton W.M., and Ben-Abdallah A. Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-lV criteria. Hum. Psychopharmacol. 16 (2001) 599-606
8. Dalley J.W., Lääne K., Theobald D.E., Peña Y., Bruce C.C., Huszar A.C., Wojcieszek M., Everitt B.J., and Robbins T.W. Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine. Neuropsychopharmacology 32 (2007) 1195-1206
9. Daniela E., Brennan K., Gittings D., Hely L., and Schenk S. Effect of SCH 23390 on (±)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats. Pharmacol. Biochem. Behav. 77 (2004) 745-750
10. Daniela E., Gittings D., and Schenk S. Conditioning following repeated exposure to MDMA in rats: role in the maintenance of MDMA self-administration. Behav. Neurosci. 120 (2006) 1144-1150
11. De La Garza II R., Fabrizio K.R., and Gupta A. Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns. Psychopharmacology (2006) 1-10
12. Fantegrossi W.E., Ullrich T., Rice K.C., Woods J.H., and Winger G. Methylenedioxymethamphetamine (MDMA, 'ecstasy') and its stereoisomers as reinforcers in rhesus monekys: serotonergic involvement. Psychopharmacology 161 (2002) 356-364
13. Gamma A. Keeping a clear head on effects of illicit drugs. Nature 430 (2004) 399
14. Gerber G.J., and Stretch R. Drug-induced reinstatement of extinguished self-administration behavior in monkeys. Pharmacol. Biochem. Behav. 3 (1975) 1055-1061
15. Gold L.H., and Koob G.F. MDMA produces stimulant-like conditioned locomotor activity. Psychopharmacology 99 (1989) 352-356
16. Hopper J.W., Su Z., Looby A.R., Ryan E.T., Penetar D.M., Palmer C.M., and Lukas S.E. Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: An ecological momentary assessment study. Drug Alcohol Depend. 85 (2006) 221-235
17. Huxster J.K., Pirona A., and Morgan M.J. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans. J. Psychopharmacol. 20 (2006) 281-290
18. Johanson C.E., Kilbey M., Gatchalian K., and Tancer M. Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo. Drug Alcohol Depend. 81 (2006) 27-36
19. Johnson M.P., Hoffman A.J., and Nichols D.E. Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. Eur. J. Pharmacol. 113 (1986) 269-276
20. Kalivas P.W., Duffy P., and White S.R. MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology 18 (1998) 469-479
21. Kelly B.C. Conceptions of risk in the lives of club drug-using youth. Subst. Use Misuse 40 (2005) 1443-1459
22. Khorana N., Pullagurla M.R., Young R., and Glennon R.A. Comparison of the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) and cocaine: asymmetric generalization. Drug Alcohol Depend. 74 (2004) 281-287
23. Kueh D., and Baker L.E. Reinforcement schedule effects in rats trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or cocaine. Psychopharmacology 189 (2007) 447-457
24. Lamb R.J., and Griffiths R.R. Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon. Psychopharmacology 91 (1987) 268-272
25. Le A.D., Quan B., Juzytch W., Fletcher P.J., Joharchi N., and Shaham Y. Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats. Psychopharmacology 135 (1998) 169-174
26. Lenoir M., and Ahmed S.H. Heroin-induced reinstatement is specific to compulsive heroin use and dissociable from heroin reward and sensitization. Neuropsychopharmacology 32 (2007) 616-624
27. Lew R., Sabol K.E., Chou C., Vosmer G.L., Richards J., and Seiden L.S. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: radioligand binding and autoradiography studies. J. Pharmacol. Exp. Ther. 276 (1996) 855-865
28. Lile J.A., Ross J.T., and Nader M.A. A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys. Drug Alcohol Depend. 78 (2005) 135-140
29. McCreary A.C., Bankson M.G., and Cunningham K.A. Pharmacological studies of the acute and chronic effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors. J. Pharmacol. Exp. Ther. 290 (1999) 965-973
30. Mechan A., Yuan J., Hatzidimitriou G., Irvine R.J., McCann U.D., and Ricaurte G.A. Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons. Neuropsychopharmacology 31 (2006) 339-350
31. Modi G.M., Yang P.B., Swann A.C., and Dafny N. Chronic exposure to MDMA (Ecstasy) elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants. Behav. Brain Funct. 2 (2006) 1
32. Murphy P.N., Wareing M., and Fisk J. Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study. J. Psychopharmacol. 20 (2006) 447-455
33. Nash J.F., and Brodkin J. Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors. J. Pharmacol. Exp. Ther. 259 (1991) 820-825
34. O'Shea E., Granados R., Esteban B., Colado M.I., and Green A.R. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). Neuropharmacology 37 (1998) 919-926
35. Partridge B., and Schenk S. Context-independent sensitization to the locomotor-activating effects of cocaine. Pharmacol. Biochem. Behav. 63 (1999) 543-548
36. Ramos M., Goni-Allo B., and Aguirre N. Studies on the role of dopamine D1 receptors in the development and expression of MDMA-induced behavioral sensitization in rats. Psychopharmacology 177 (2004) 100-110
37. Ramos M., Goni-Allo B., and Aguirre N. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT(2C) receptor stimulation and not by D(1) receptor blockade. Neuropsychopharmacology 30 (2005) 2180-2191
38. Ratzenboeck E., Saria A., Kriechbaum N., and Zernig G. Reinforcing effects of MDMA ("ecstasy") in drug-naive and cocaine-trained rats. Pharmacology 62 (2001) 138-144
39. Sabol K.E., Lew R., Richards J.B., Vosmer G.L., and Seiden L.S. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: synaptosomal uptake and tissue concentrations. J. Pharmacol. Exp. Ther. 276 (1996) 846-854
40. Scanzello C.R., Hatzidimitriou G., Martello A.L., Katz J.L., and Ricaurte G.A. Serotonergic recovery after (±)3,4-(methylenedioxy) methamphetamine injury: observations in rats. J. Pharmacol. Exp. Ther. 264 (1993) 1484-1491
41. Schenk S., and Gittings D. Effects of SCH 23390 and eticlopride on cocaine-seeking produced by cocaine and WIN 35, 428 in rats. Psychopharmacology 168 (2003) 118-123
42. Schenk S., Gittings D., Johnstone M., and Daniela E. Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology 169 (2003) 21-27
43. Schenk S., and Partridge B. Cocaine-seeking produced by experimenter-administered drug injections: dose-effect relationships in rats. Psychopharmacology 147 (1999) 285-290
44. Schenk S., and Partridge B. Influence of a conditioned light stimulus on cocaine self-administration in rats. Psychopharmacology 154 (2001) 390-396
45. Schenk S., Hely L., Lake B., Daniela E., Gittings D., and Mash D.C. MDMA self-administration in rats: Acquisition, progressive ratio responding and serotonin transporter binding. Eur. J. Neuosci. 26 (2007) 3229-3236
46. Schenk S., Horger B.A., Peltier R., and Shelton K. Supersensitivity to the reinforcing effects of cocaine following 6-hydroxydopamine lesions to the medial prefrontal cortex in rats. Brain Res. 543 (1991) 227-235
47. Schmidt C.J. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 240 (1987) 1-7
48. Schmidt C.J., and Taylor V.L. Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine. Biochem. Pharmacol. 36 (1987) 4095-4102
49. Schmidt C.J., and Taylor V.L. Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons. Eur. J. Pharmacol. 156 (1988) 121-131
50. Shalev U., Grimm J.W., and Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol. Rev. 54 (2002) 1-42
51. Stretch R., and Gerber G.J. Drug-induced reinstatement of amphetamine self-administration behaviour in monkeys. Can. J. Psychol. 27 (1973) 168-177
52. Topp L., Hando J., Dillon P., Roche A., and Solowij N. Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend. 55 (1999) 105-115
53. Tran-Nguyen L.T., Bellew J.G., Grote K.A., and Neisewander J.L. Serotonin depletion attenuates cocaine seeking but enhances sucrose seeking and the effects of cocaine priming on reinstatement of cocaine seeking in rats. Psychopharmacology 157 (2001) 340-348
54. Winstock A.R., Griffiths P., and Stewart D. Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug Alcohol Depend. 64 (2001) 9-17